H2azapa: a Versatile Acyclic Multifunctional Chelator for 67Ga, 64Cu, 111In, and 177Lu
- 29 October 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 51 (22) , 12575-12589
- https://doi.org/10.1021/ic302225z
Abstract
Preliminary experiments with the novel acyclic triazole-containing bifunctional chelator H2azapa and the radiometals 64Cu, 67Ga, 111In, and 177Lu have established its significant versatile potential as an alternative to 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) for metal-based radiopharmaceuticals. Unlike DOTA, H2azapa radiolabels quantitatively with 64Cu, 67Ga, 111In, and 177Lu in 10 min at room temperature. In vitro competition experiments with human blood serum show that 64Cu remained predominantly chelate-bound, with only 2% transchelated to serum proteins after 20 h. Biodistribution experiments with [64Cu(azapa)] in mice reveal uptake in various organs, particularly in the liver, lungs, heart, intestines, and kidneys. When compared to [64Cu(DOTA)]2–, the lipophilic neutral [64Cu(azapa)] was cleared through the gastrointestinal tract and accumulated in the liver, which is common for lipophilic compounds or free 64Cu. The chelator H2azapa is a model complex for a click-based bifunctional chelating agent, and the lipophilic benzyl “place-holders” will be replaced by hydrophilic peptides to modulate the pharmacokinetics and direct activity away from the liver and gut. The solid-state molecular structure of [In(azapa)(H2O)][ClO4] reveals a very rare eight-coordinate distorted square antiprismatic geometry with one triazole arm bound, and the structure of [64Cu(azapa)] shows a distorted octahedral geometry. The present study demonstrates significant potential for bioconjugates of H2azapa as alternatives to DOTA in copper-based radiopharmaceuticals, with the highly modular and “clickable” molecular scaffold of H2azapa easily modified into a variety of bioconjugates. H2azapa is a versatile addition to the “pa” family, joining the previously published H2dedpa (67/68Ga and 64Cu), H4octapa (111In, 177Lu, and 90Y), and H5decapa (225Ac) to cover a wide range of important nuclides.This publication has 64 references indexed in Scilit:
- Synthesis, Cu(ii) complexation,64Cu-labeling and biological evaluation of cross-bridged cyclam chelators with phosphonate pendant armsDalton Transactions, 2011
- Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapyNuclear Medicine and Biology, 2011
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of DiseaseChemical Reviews, 2010
- PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A″-DTPA-cetuximabEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical ResearchCancer Biotherapy & Radiopharmaceuticals, 2009
- 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activityNuclear Medicine and Biology, 2009
- Efficient production of high specific activity 64Cu using a biomedical cyclotronNuclear Medicine and Biology, 1997
- Copper radionuclides and radiopharmaceuticals in nuclear medicineNuclear Medicine and Biology, 1996
- New hydroxybenzyl and hydroxypyridylmethyl substituted triazacyclononane ligands for use with gallium(III) and indium(III)Nuclear Medicine and Biology, 1995
- SEVEN- AND EIGHT-COORDINATE COMPLEXES OF INDIUM(III) WITH NITRILOTRIACETATEMain Group Metal Chemistry, 1994